View Clinical Trial (Medical Research Study)
Treatment of Early Nasal Polyposis With Topical Triamcinolone
| City: |
|
Brighton |
| State: |
|
Massachusetts |
| Zip Code: |
|
02135 |
| Conditions: |
|
Nasal Polyps |
| Purpose: |
|
The purpose of this study is to compare the effectiveness of intranasal Triamcinolone
delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked
dressing, in the treatment and prevention of early nasal polyposis.
|
| Study Summary: |
|
Nasopore, a bio-absorbable nasal dressing, may offer an alternative route of sustained
steroid drug delivery. The use of topical targeted intranasal steroids may prevent the
routine adverse effects of oral steroids while maintaining the same therapeutic / clinical
efficacy.
|
| Criteria: |
|
Inclusion Criteria:
- Age > 18 years
- Patients with early nasal polyposis
Exclusion Criteria:
- Age < 18 years
- Patients with active sinus infections
- Patients on long term steroids
- Allergy or sensitivity to steroids
- Patients with Antrochoanal polyps
- Patients who received topical steroids by bio-resorbable sponge or oral steroids
|
| NCT ID: |
|
NCT01222871 |
| Primary Contact: |
|
Study Director
Peter Catalano, MD
Steward St. Elizabeth's Medical Center of Boston, Inc.
Peter Catalano, MD
Phone: 617-789-6440
Email: peter.catalano@steward.org
|
| Backup Contact: |
|
Email: robert.keller@steward.org
Robert Keller, RN/CRNA
Phone: 617-779-6455
|
| Location Contact: |
|
Brighton, Massachusetts 02135
United States
Peter Catalano, MD
Phone: 617-789-6440
Email: peter.catalano@steward.org
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|